EMPATECH LINA 25/5 is a fixed-dose combination tablet containing two potent antidiabetic agents: empagliflozin 25MG and linagliptin 5MG. This medication is intended specifically to manage and improve blood sugar control in adults with type 2 diabetes. It is a modern approach to diabetes care that combines the complementary mechanisms of these two active ingredients to provide effective glycemic control. Empagliflozin helps the kidneys eliminate excess glucose through urine, whereas Linagliptin improves the body's insulin response by increasing incretin hormone levels, which regulate blood sugar after meals. To maximize its efficacy, EMPATECH LINA 25/5 is typically prescribed in conjunction with a well-balanced diet and regular exercise.This combination is particularly useful for patients who require more than one mode of action to stabilize their blood sugar levels effectively.
What is the EMPATECH LINA 25/5?
EMPATECH LINA 25/5 is a tablet that contains 25 mg of Empagliflozin and 5 mg of Linagliptin. It is an oral anti-diabetic medication that reduces high blood sugar levels in type 2 diabetes patients by improving the body's glucose and insulin metabolism. This medication takes a dual approach: Empagliflozin reduces glucose reabsorption in the kidneys, causing excess glucose to be excreted in the urine, whereas Linagliptin increases incretin hormone levels, which stimulate insulin release and reduce sugar production by the liver.
Applications of EMPATECH LINA 25/5
To enhance glycemic control in adults with type 2 diabetes.
To be used in conjunction with a healthy diet and regular exercise to effectively lower blood sugar.
May be prescribed for patients who are not adequately controlled on metformin or other antidiabetic medications.
Helps to reduce the risk of cardiovascular complications caused by type 2 diabetes.
Suitable for patients who are intolerant to metformin or require multiple drug mechanisms for optimal control.
Side Effects of EMPATECH LINA 25/5
Urinary tract infections caused by elevated glucose levels in urine.
Fungal infections of the genitals.
Nasopharyngitis (common cold symptoms include nasal congestion and a sore throat).
Hypoglycemia (low blood sugar), particularly when combined with other diabetes medications.
Increased urination.
Thirst and dehydration may occur if there is significant fluid loss.
In some cases, gastrointestinal symptoms may include nausea, vomiting, or constipation.
Ketoacidosis is a rare but serious side effect that can occur when acids called ketoacids accumulate in the blood.
Precautions Before Using EMPATECH LINA 25/5.
Inform your doctor if you have kidney or liver problems.
Mention any previous urinary tract or genital infections.
Pregnancy and breastfeeding status should be communicated; use during these times requires caution.
Avoid use if you have diabetic ketoacidosis symptoms.
Ensure that your doctor is aware of all other medications and supplements you are taking.
Maintain proper hydration to avoid dehydration.
Regular blood sugar monitoring is essential for avoiding hypoglycemia.
Use with caution in elderly patients and those with low blood pressure.
Find products similar to Empagliflozin And Linagliptin Tablets, 25mg/5mg
Steris is known as one of the Best PCD Pharma Franchise Companies in India. As a Trusted PCD Pharma Company, we are committed to offering the Best Pharma Products in India with a focus on quality, innovation, and customer satisfaction.
Steris Pharma stands among the Leading PCD Pharma Companies in India, delivering a wide range of high-quality pharmaceutical products. Our product portfolio covers multiple therapeutic segments such as Asthma, Cardiology, Nephrology, Neurology, Respiratory, Urology, Diabetology, Orthopedics, General Medicine, Gynaecology, and Gastroenterology, along with many others.
From a client's perspective, we strictly follow ethical business practices, which make us a reliable and trusted business associate among healthcare professionals across India.
Join hands with Steris Pharma today to grow your business with one of the most reputed names in the Indian PCD Pharma Industry. We also export our pharmaceutical and healthcare products to various international markets, maintaining the highest global standards through WHO-GMP and ISO-certified manufacturing facilities. Our export operations ensure timely delivery, premium quality, and complete customer satisfaction across different countries.
Steris Pharma stands among the Leading PCD Pharma Companies in India, delivering a wide range of high-quality pharmaceutical products. Our product portfolio covers multiple therapeutic segments such as Asthma, Cardiology, Nephrology, Neurology, Respiratory, Urology, Diabetology, Orthopedics, General Medicine, Gynaecology, and Gastroenterology, along with many others.
From a client’s perspective, we strictly follow ethical business practices, which make us a reliable and trusted business associate among healthcare professionals across World
